MedOne, an innovative pharmacy benefit manager (PBM) focused on outcomes-driven care, and Nanodropper, a leader in precision medication delivery solutions, announced early results from the MediSplit program, a value-based clinical care path designed to improve medication adherence and reduce side effects for patients using prescription eye drops.
The MediSplit program provides eligible MedOne members with complimentary Nanodroppers when filling select ophthalmic prescriptions. The initiative aims to address common challenges associated with eye drop medications, including waste, inconsistent dosing, and treatment-related side effects.
Nanodropper's device reduces the volume of each eye drop, helping patients extend the life of their medication while minimising systemic exposure that can contribute to side effects. When deployed at scale through MedOne's pharmacy network, the solution offers a promising pathway for improved outcomes and cost efficiencies.
Early outcomes from the program demonstrate significant improvements in both adherence and patient experience:
100 per cent of participants reported never missing a dose due to running out of medication, compared to 40 per cent before using Nanodropper
100 per cent reported never missing a dose due to unwanted side effects, down from 20 per cent
100 per cent of participants indicated they would like to continue receiving Nanodroppers
36 per cent reported a reduction in side effect prevalence, while 53 per cent reported a reduction in side effect severity
These results highlight the potential of pairing innovative medical devices with pharmacy benefits to drive meaningful clinical and behavioural outcomes.
"The partnership with Nanodropper adds an innovative enhancement to this clinical program focusing on limiting waste and delivering savings to clients and patients," said Dr Nathan Harold, Chief Pharmacy Officer at MedOne. "Our clients trust us to be responsible stewards of their resources and the MediSplit program is one of our many strategies that keep their best interests in mind."
The MediSplit program represents a new model for pharmacy benefit design: integrating medical devices as value-based services. By aligning incentives around outcomes rather than utilisation, the program demonstrates how simple, low-cost interventions can significantly enhance both patient adherence and overall treatment experience.
